Cutting-edge biotech production facility planned in Debrecen


Debrecen/Budapest – Hungary’s leading pharmaceutical company Gedeon Richter Plc. is continuing to expand its activities in biotechnological R&D and manufacturing of therapeutic proteins. After the establishment of Richter-Helm in Germany, a joint venture of Gedeon Richter and Hamburg-based Helm AG one year ago, the Hungarian company announced in August that it will build a a63m multi-purpose plant for the production of biopharmaceuticals in insect and mammalian cells at Debrecen. The company says that the novel unit, which will create 110 new jobs and is expected to be operational by 2012, will be “one of kind in Central and Eastern Europe, and will also be a significant step forward in enhancing the competitiveness of Hungary.”

Plant to go online by 2012

Gedeon Richter, which will start construction of the new production plant in Debrecen’s industrial park this year, did not discuss how much money the Hungarian government will contribute to the prestigous project. But local authorities might have sold Richter the land under market prices and granted a local tax concession, according to reports from the regional press.
Besides the production of therapeutic proteins in insect and mammalian cells, the GMP-compliant plant will also be suitable for other technologies with minimal modification, according to Gedeon Richter. Initially, the new site will produce clinical trials materials, but from 2014 the company plans to switch to production of drugs for the pharmaceutical market.



Budapest/Zug/Edinburgh – Swiss/Hungarian antibody specialist ImmunoGenes has inked a collaboration and license agreement with the Scottish Roslin Institute to develop specialised sheep that use ImmunoGenes’ proprietary technology...



Budapest – Mecsek Pharma has won a HUF1bn (EUR3.6m) state grant that will allow the company to test the insulin sensitiser BGT-15 in a Phase IIb clinical trial, according to Mecsek’s parent company Phylaxia Holding. BGT-15 is a...



Budapest – California-based biotech company Codexis plans to expand its expertise in fermentation technology. In August, Codexis’ CEO Alan Shaw announced that the firm will expand its activities in fermentation technology in...



Budapest – UK clinical research organisation Chiltern International Ltd has opened a new office in Budapest. The branch will be led by Dr. Attila Lorinczi , a member of the Hungarian Medical Society and the Society of Hungarian...



Budapest – The European Institute of Innovation and Technology (EIT) launched a call for proposals for its first Knowledge and Innovation Communities (KICs) at the beginning of April ( The call will remain...



Budapest/Brussels – The Budapest-based European Institute of Technology (EIT, has received its first governing board. The 18 members, who held the board’s inaugural meeting on the occasion of the EIT’s...



Budapest/Brussels – The European research ministers decided in mid-June that the Hungarian capital Budapest will house the headquarters of the prestigious European Institute of Technology (EIT). With a budget of EUR308m until...



Geneva – Ernesto Bertarelli, the Swiss-Italian biotech billionaire who sold his company Serono SA, has returned to the front lines of the pharma business as his new EUR1bn healthcare fund joined with Merrill Lynch to buy...



Bucharest – Three years ago, Romania was Europe’s largest cultivator of genetically modified plants (87,600 hectares of GM soy acreage). With acession, the government there had to halt the cultivation of the GM crops not approved...



Zagreb – Pliva d.d., Barr Pharmaceuticals‘ subsidiary in Croatia, is selling its three operations in Spain – Pliva Pharma Iberia, Laboratorios Edigen and Uso Racional – to Biomedica Foscama Industria Chimico-Farmaceutica. For a...

Displaying results 11 to 20 out of 89

< Previous 11-20 Next >

© 2007-2015 BIOCOM


All Events


Product of the week


Current issue

All issues